Table 3.
Univariate analysis of DFS and OS according to clinical characteristics
| DFS | OS | |||
|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | |
| Family history of cancer |
||||
| No | 1.00 | 1.00 | ||
| Yes | 1.34 (0.56-3.24) | .511 | 0.88 (0.29-2.63) | .822 |
| Bilateral tumors | ||||
| No | 1.00 | 1.00 | ||
| Yes | NE | – | NE | – |
| Residual disease | ||||
| No | 1.00 | 1.00 | ||
| Yes | 6.09 (2.41-15.38) | .0001 | 3.80 (1.31-10.98) | .014 |
| Stage | ||||
| I | 1.00 | 1.00 | ||
| II | 3.57 (0.99-12.90) | NE | ||
| III | 7.42 (1.94-28.42) | .013 | NE | – |
Univariate analysis of DFS and OS according to clinical characteristics.
Abbreviations: DFS, disease -free survival; NE, not estimable, OS, overall survival.